2006 Collective Compliance Medicine 
Cannabis Law Report
JULY 20, 2021
Compliance Division – Richard Parrott. Collectively, these dedicated public servants bring extensive experience from the state and local level to the leadership team. Compliance Division – Richard Parrott. Chief Deputy Director – Rasha Salama. General Counsel – Matthew Lee. Administration Division – Melissa Eidson.
Cannabis Law Report
FEBRUARY 16, 2022
Founded in California in 2006, Harborside was awarded one of the first six medical cannabis licenses granted in the United States. Additional information regarding Harborside is available under Harborside’s SEDAR profile at www.sedar.com.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
AUGUST 8, 2019
investment community as to the boundaries of legal risk and compliance. the sale of shares or assets and collection of dividends outside the U.K. There is very little guidance for U.K. businesses with regards to cannabis-related activity and significant discrepancy in opinion within the U.K. On 18 June 2019, the U.K. Source: [link].
Cannabis Law Report
NOVEMBER 29, 2021
The directors and officers and certain shareholders of Urbn Leaf, collectively holding approximately 69% of Series A shares and 96% of common shares, have entered into voting and support agreements to vote in favour of the Urbn Leaf Transaction. The Urbn Leaf Transaction has been unanimously approved by the board of directors of Urbn Leaf.
Cannabis Law Report
MAY 26, 2022
A report by the National Academies of Sciences, Engineering, and Medicine (2017) concluded that there is “substantial evidence of a statistical association between cannabis use and increased risk of motor vehicle crashes” (p 9–11) based upon systematic reviews of the evidence (Asbridge et al., 2006, Freisthler et al., Discussion.
Cannabis Law Report
OCTOBER 12, 2019
“ The referendum must collect 50,000 signatures for the project to be debated in Parliament, and collected half of it at the time of writing. The prescription rates fell in 2018 to 269 prescriptions, partly due to governmental authorities adopting a strict approach to the regulation of cannabis as medicine.
Cannabis Law Report
MARCH 25, 2019
The DEA has made previous requests–in 2001 and 2006–to the FDA for an evaluation of marijuana. Trafficking in cannabis in compliance with state law will no longer constitute a predicate act to establish violations of other federal criminal laws under the CSA, in particular financial crimes such as money laundering laws.
Expert insights. Personalized for you.
105 
Let's personalize your content